Bicycle Therapeutics plc (BCYC)

NMS – Real Time Price. Currency in USD

4.72

+0.02 (0.43%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

73M

35M

27M

14M

Cost of goods sold

-6M

-7M

-4M

Gross Profit

66M

28M

21M

11M

Operating expenses (excl. COGS)

-350M

-281M

-236M

-149M

Operating Income

-283M

-252M

-216M

-138M

Non-operating income, total

29M

35M

11M

Pretax income

-254M

-217M

-204M

-135M

Equity in earnings

Taxes

35M

48M

23M

22M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-219M

-169M

-181M

-113M

Bicycle Therapeutics plc (BCYC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicycle Therapeutics plc (BCYC)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Bicycle Therapeutics plc (BCYC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bicycle Therapeutics plc (BCYC)

Income Statement (Annual)

Income Statement (Annual)